Plasmacytoma/multiple myeloma type posttransplant lymphoproliferative disorder

por Claushuis, Theodora A.M., Tick, Lidwine W., van Zwam, Peter
Publicado 2022

Two Cases of Q-Fever in Hairy Cell Leukemia

por Ammatuna, Emanuele, Iannitto, Emilio, Tick, Lidwine W., Arents, Nicolaas L. A., Kuijper, Philip H., Nijziel, Marten R.
Publicado 2014

Comparing Survivors of Cancer in Population-Based Samples With Those in Online Cancer Communities: Cross-sectional Questionnaire Study

por van Eenbergen, Mies C, Vromans, Ruben D, Tick, Lidwine W, Vreugdenhil, Gerard, Krahmer, Emiel J, Mols, Floortje, van de Poll-Franse, Lonneke V
Publicado 2022

Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice

por Oerlemans, Simone, Bennink, M. Christine, Levin, Mark David, Broijl, Annemiek, Van der Klift, Marjolein, Van Deursen, Judith, Vogels, Daphne, Van de Poll-Franse, Lonneke V., Sonneveld, Pieter, Hazelzet, Jan A., Tick, Lidwine W.
Publicado 2020

Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study

por Kersten, Marie José, Amaador, Karima, Minnema, Monique C., Vos, Josephine M. I., Nasserinejad, Kazem, Kap, Marcel, Kastritis, Efstathios, Gavriatopoulou, Maria, Kraan, Willem, Chamuleau, Martine E. D., Deeren, Dries, Tick, Lidwine W., Doorduijn, Jeanette K., Offner, Fritz, Böhmer, Lara H., Liu, Roberto D., Pals, Steven T., Dimopoulos, Meletios A.
Publicado 2022

Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia

por Grob, Tim, Sanders, Mathijs A., Vonk, Christian M., Kavelaars, Franҫois G., Rijken, Melissa, Hanekamp, Diana W., Gradowska, Patrycja L., Cloos, Jacqueline, Fløisand, Yngvar, van Marwijk Kooy, Marinus, Manz, Markus G., Ossenkoppele, Gert J., Tick, Lidwine W., Havelange, Violaine, Löwenberg, Bob, Jongen-Lavrencic, Mojca, Valk, Peter J.M.
Publicado 2023

CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis on Preventing Post‐Thrombotic Syndrome) Trial: Long‐Term Follow‐Up Results

por Notten, Pascale, de Smet, André A. E. A., Tick, Lidwine W., van de Poel, Marlène H. W., Wikkeling, Otmar R. M., Vleming, Louis‐Jean, Koster, Ad, Jie, Kon‐Siong G., Jacobs, Esther M. G., Ebben, Harm P., Coppens, Michiel, ten Cate, Hugo, Wittens, Cees H. A., ten Cate‐Hoek, Arina J.
Publicado 2021

Clinical impact of assessing thrombus age using magnetic resonance venography prior to catheter-directed thrombolysis

por Arnoldussen, Carsten W. K. P., Notten, Pascale, Brans, Rutger, Vroegindeweij, Dammis, Tick, Lidwine W., van de Poel, Marlène H. W., Wikkeling, Otmar R. M., Vleming, Louis-Jean, Koster, Ad, Jie, Kon-Siong G., Jacobs, Esther M. G., Planken, Nils, Wittens, Cees H. A., ten Cate, Hugo, Wildberger, Joachim E., ten Cate-Hoek, Arina J.
Publicado 2022

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE...

por Groen, Kaz, Stege, Claudia, Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, van de Donk, Niels W.C.J., Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja
Publicado 2023

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial

por Groen, Kaz, Stege, Claudia A.M., Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., Verbrugge, Annelies, Buitenhuis, Danny, Cunha, Sonia M., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., van de Donk, Niels W.C.J., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja
Publicado 2023

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial

por Chamuleau, Martine E.D., Burggraaff, Coreline N., Nijland, Marcel, Bakunina, Katerina, Mous, Rogier, Lugtenburg, Pieternella J., Dierickx, Daan, van Imhoff, Gustaaf W., Vermaat, Joost S.P., A.F.Marijt, Eric, Visser, Otto, Mandigers, Caroline, Bilgin, Yavuz M., Beeker, Aart, Durian, Mark F., van Rees, Bas P., Bohmer, Lara H., Tick, Lidwine W., Boersma, Rinske S., Snijders, Tjeerd J.F., Schouten, Harry C., Koene, Harry R., de Jongh, Eva, Hijmering, Nathalie, Diepstra, Arjan, van de Berg, Anke, Arens, Anne I.J., Huijbregts, Julia, Hoekstra, Otto, Zijlstra, Josee M., de Jong, Daphne, Kersten, Marie José
Publicado 2019

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial

por Rijneveld, Anita W., van der Holt, Bronno, de Weerdt, Okke, Biemond, Bart J., van de Loosdrecht, Arjen A., van der Wagen, Lotte E., Bellido, Mar, van Gelder, Michel, van der Velden, Walter J. F. M., Selleslag, Dominik, van Lammeren-Venema, Daniëlle, Halkes, Constantijn J. M., Fijnheer, Rob, Havelange, Violaine, van Sluis, Geerte L., Legdeur, Marie-Cecile, Deeren, Dries, Gadisseur, Alain, Sinnige, Harm A. M., Breems, Dimitri A., Jaspers, Aurélie, Legrand, Ollivier, Terpstra, Wim E., Boersma, Rinske S., Mazure, Dominiek, Triffet, Agnes, Tick, Lidwine W., Beel, Karolien, Maertens, Johan A., Beverloo, H. Berna, Bakkus, Marleen, Homburg, Christa H. E., de Haas, Valerie, van der Velden, Vincent H. J., Cornelissen, Jan J.
Publicado 2022